SSY Groups (HKG:2005) attributable profit fell 20% to HK$1.06 billion in 2024 from HK$1.32 billion in 2023, according to a Friday filing with the Hong Kong bourse.
Earnings per share at the drug company decreased to HK$0.3581 from HK$0.4426 in the previous year.
Revenue declined 11% to HK$5.77 billion from HK$6.46 billion a year earlier.
The company declared a final dividend of HK$0.095 per share, payable June 3 to shareholders on record as of May 21.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。